Recon: Patent office sides with Merck in fight over injectable Keytruda; Sarepta picks up platform technology designation for gene therapy vector
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States